Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04488744 · ClinicalTrials.gov registry record · Early Phase 1
Smoking by IV Pulsed Nicotine
A Early Phase 1 study of Smoking Cessation, sponsored by Yale University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 13
- Enrollment target
- 1
- Study location
NCT04488744 is a Early Phase 1 study of Smoking Cessation that has completed, run by Yale University. The registered enrollment target is 13 participants, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04488744, a Early Phase 1 study of Smoking Cessation, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 13 participants
- Enrollment target
- 1
- Study location
Study Summary
To establish a dose-effect curve for nicotine's abuse potential as a function of nicotine dose and delivery rate. Pulsed IV nicotine administration will be used as it closely matches nicotine delivery by inhaled tobacco use.
Conditions Studied
Interventions
- DRUG Nicotine 0.2mcg/kg/s and 1.0mcg/kg/s
Study Locations (1)
Connecticut
- Veterans Affairs Hospital - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2021-05-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04488744
The ClinicalTrials.gov registry entry for NCT04488744 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 475-participant average among 188 other Smoking Cessation trials with a reported enrollment target (97% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Nicotine 0.2mcg/kg/s and 1.0mcg/kg/s is the first listed.
NCT04488744 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04488744 about?
NCT04488744 is a clinical study titled "Smoking by IV Pulsed Nicotine". To establish a dose-effect curve for nicotine's abuse potential as a function of nicotine dose and delivery rate. Pulsed IV nicotine administration will be used as it closely matches nicotine delivery by inhaled tobacco use.
What is the current status of trial NCT04488744?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 13 participants. The study started on 2019-11-15. Estimated completion is 2021-05-31.
What conditions does trial NCT04488744 study?
This clinical trial studies the following conditions: Smoking Cessation.
What interventions are being tested in trial NCT04488744?
The interventions under investigation include: Nicotine 0.2mcg/kg/s and 1.0mcg/kg/s (DRUG).
Who is sponsoring clinical trial NCT04488744?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04488744 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Smoking Cessation Treatment for Head & Neck Cancer Patients
ACTIVE NOT RECRUITING · Early Phase 1
-
End Nicotine Dependence Clinic
COMPLETED · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Applying mHealth to Tobacco-related Health Disparities
COMPLETED · Early Phase 1
-
Ketamine and Motivational Enhancement Therapy for the Treatment of Tobacco Use Disorder
COMPLETED · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.